Emerging immunotherapeutics for immune activation and tolerance

Affiliations

• ¹ Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, 20 N. Pine Street, Baltimore, MD, 21201, USA. rpearson@rx.umaryland.edu.
• ² Department of Microbiology and Immunology, University of Maryland School of Medicine, 685 W. Baltimore Street, Baltimore, MD, 21201, USA. rpearson@rx.umaryland.edu.
• ³ Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, 22 S. Greene Street, Baltimore, MD, 21201, USA. rpearson@rx.umaryland.edu.
• ⁴ Chemical Engineering, School for the Engineering of Matter, Transport, and Energy, Arizona State University, Tempe, AZ, 85281, USA.
• ⁵ Biological Design, School for the Engineering of Matter, Transport, and Energy, Arizona State University, Tempe, AZ, 85281, USA.
• ⁶ Biomedical Engineering, School of Biological and Health Systems Engineering, Arizona State University, Tempe, AZ, 85281, USA.
• ⁷ Materials Science and Engineering, School for the Engineering of Matter, Transport, and Energy, Arizona State University, Tempe, AZ, 85281, USA.
• ⁸ Biodesign Center for Immunotherapy, Vaccines and Virotherapy, Arizona State University, Tempe, AZ, 85281, USA.
• ⁹ Department of Pharmaceutical Sciences, University of Michigan, Ann Arbor, MI, 48109, USA.
• ¹⁰ Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI, 48109, USA.
• ¹¹ Department of Chemical Engineering, University of Michigan, Ann Arbor, MI, 48109, USA.
• ¹² Biointerfaces Institute, University of Michigan, Ann Arbor, MI, 48109, USA.